ORTEXORTEX News
Tracking PRHI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
PR
Trader NotePRHI

PRHI CEO buys stock as Q1 results show improving losses

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 13 May 2026, 23:10

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Presurance Holdings is a micro-cap insurance name that just dropped fresh quarterly numbers — and the setup heading into the week tells two competing stories at once.

Q1 adjusted EPS came in at -$0.16, a meaningful improvement from -$0.30 a year ago. That signals loss-narrowing progress. But top-line revenue fell sharply, dropping to $5.9 million from $10.3 million in the year-ago quarter. For a company at this stage, that revenue contraction is the harder number to dismiss.

The borrow market for PRHI is notable for how quiet it actually is. Availability is extremely loose — availability runs at roughly 6,250% of short interest, meaning the lending pool is essentially unused. Cost to borrow has eased to 8.9%, down more than 27% on the week from a March peak above 17%. Short interest itself remains negligible at just 0.065% of the free float, even with the raw share count roughly doubling over the past week to around 11,200 shares. At these absolute levels, the short side of the trade is barely a rounding error. Borrow availability tightened sharply back in early April — utilization briefly hit 13.7% on April 2 before collapsing to 3.2% today — but that episode has fully unwound.

The more interesting ownership story is concentrated control. Clarkston Capital Partners and Clarkston Ventures together hold roughly 65% of the company, with both positions reported as of late April. CEO Brian Roney added 100,000 shares on April 1 at $0.7181, a purchase worth about $71,800. Board chair James Grant Smith has been a consistent buyer too, adding shares in early and mid-April at prices between $0.74 and $0.80. These are small dollar amounts for individual transactions, but the pattern of executive buying into weakness is consistent.

Earnings history has been volatile. The April 1 event produced a one-day gain of 51.5% and a five-day gain of 48.5%. The prior event in late March triggered a one-day decline of 21.6% before recovering to a five-day gain of 30.7%. The November 2025 print fell 11.8% on the day and finished the week down 2.5%. The swings suggest thin liquidity amplifies moves in both directions rather than any clear directional pattern.

With Q1 results now published and a proxy statement filed for a June 3 annual meeting, the next event to track is the May 20 earnings call, which will give management a chance to explain the revenue trajectory and whether the improving loss ratio is sustainable at lower premium volumes.

Stocks in this article

See the live data behind this article on ORTEX.

Open PRHI on ORTEX →

How this article was generated

Generated
13 May 2026, 23:11
Data as of
13 May 2026, 23:10
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationEarningsInstitutional positioningORTEX Alpha signals

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.